Premier Alternatives

Hyalex Orthopaedics

Lexington, MA · Founded 2016 · Privately Held (backing)

Developer of a biomimetic material designed to simulate cartilages for diseased and damaged joints. Hyalex Orthopaedics is based in Lexington, MA and was founded in 2016. Its last known valuation is $68.9 million. It has raised $47.9 million across 2 recorded rounds; the latest was a $14.9 million early-stage round in Sep 2024.

Last price · $/share
—
Implied valuation
$68.9M
Total raised
$47.9M
Last round
Early Stage VC
Sep 2024

Hyalex Orthopaedics key facts

  • Developer of a biomimetic material designed to simulate cartilages for diseased and damaged joints.
  • Hyalex Orthopaedics’s last known valuation is $68.9M.
  • It has raised $47.9M across 2 recorded rounds; the latest was Early Stage VC ($14.9M) in Sep 2024.
  • Notable investors include MedTech Innovator, Canaan Partners, Johnson & Johnson JJDC, Osage University Partners, Treo Ventures — 7 tracked in total.
  • Hyalex Orthopaedics has filed 4 Form Ds with the SEC since 2017, most recently Oct 2024 ($14.9M sold to 7 investors).
  • Status: Privately Held (backing).
Free account
More of Hyalex Orthopaedics with a free account
  • ·Watch Hyalex Orthopaedics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Hyalex Orthopaedics funding rounds

2 rounds
Sep 2024Early Stage VC$14.9MSEC filing▮
May 2017Early Stage VC$30.6MSEC filing▮
Full funding history →

Hyalex Orthopaedics valuation

Hyalex Orthopaedics's last known valuation is $68.9 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How much has Hyalex Orthopaedics raised?

Hyalex Orthopaedics has raised $47.9 million across 2 recorded rounds since 2017. The largest was a $30.6 million early-stage round in May 2017; the most recent was a $14.9 million early-stage round in Sep 2024.

Hyalex Orthopaedics has filed 4 Form Ds with the SEC since 2017, most recently in Oct 2024 ($14.9 million sold to 7 investors).

Hyalex Orthopaedics investors

7 investors are on record for Hyalex Orthopaedics, including MedTech Innovator, Canaan Partners, Johnson & Johnson JJDC and Osage University Partners. The early-stage round in Sep 2024 drew 7 investors.

About Hyalex Orthopaedics

Developer of a biomimetic material designed to simulate cartilages for diseased and damaged joints. The company's synthetic material can maintain low friction and wear under high loads encountered in human joints, enabling doctors to replace arthritic cartilage while sparing healthy bone.

Sector
Healthcare
HQ
Lexington, MA, United States
Founded
2016
Employees
24
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.

Valuation on record
$68.9M

Hyalex Orthopaedics’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.